Passa al contenuto
Merck
  • Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.

Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.

Journal of travel medicine (2012-04-26)
Sabine Stauga, Stefan Schmiedel
ABSTRACT

Cerebral alveolar echinococcosis (AE) is a rare and difficult-to-treat zoonosis caused by Echinococcus multilocularis. A 29-year-old immigrant from Siberia with a past history of hepatic AE, presented with acute onset of grand mal seizures, weakness of the left leg, and cephalgia. Magnetic resonance imaging of the brain revealed inoperable right-sided infiltrative lesions, suggesting cerebral AE. Despite anthelmintic treatment only slow improvement occurred.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Supelco
Albendazole sulfoxide, VETRANAL®, analytical standard